Received Oct 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9C295-PVT | IM / LL |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | 4 | UK175AB- PVT | IM / RL |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Z002399 | IM / RL |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3Z34X- PVT | PO / MO |
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 9C295-PVT | IM / LL |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | 1 | UK175AB-PVT | IM / RL |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Z002399 | ID / RL |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 3Z34X-PVT | PO / MO |
Provider ordered Prevnar 20, however, HPV (Gardasil 9) was administered to the patient. The provider notified the patient mother of the administration error and counseled the mother on signs/symptoms to monitor for. Instructed mother to notify the provider for any concerns. The have been no reported adverse events as of 10/23/2025.
None
None
None; RSV (BEYFORTIS)
None
None